Loading live market data…

electroCore, Inc.

NASDAQ:ECOR

$6.15 USD

-$0.37 (-5.67%)

Volume
83.12K
Average Volume
109.74K
Market Capitalization
$51.02M
P/E Ratio
-3.40
Dividend Yield
0.00%
Price Target
$
Year High
$10.50
Year Low
$4.16
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.02
Source Headline
electroCore, Inc. (ECOR) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript

electroCore, Inc. (ECOR) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript

seekingalpha.com - 2026-06-23 16:02:14

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23-24, 2026.

globenewswire.com - 2026-06-17 08:00:00

RBC reiterates 'outperform' on Ecora Royalties after Voisey's Bay site visit boosts confidence

RBC Capital Markets has reiterated its 'outperform' rating and 185p price target on Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) after a site visit to the Voisey's Bay cobalt and copper mine in Newfoundland and Labrador left the bank with materially greater confidence in the asset's operational delivery and growth potential. The note, from analysts Ben Davis, Laura Chan and Marina Calero, describes a step-change in execution at Voisey's Bay, where the transition to underground mining is now largely complete with throughput running at nameplate capacity.

proactiveinvestors.co.uk - 2026-06-15 10:31:52

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the review article, "Without getting under your skin: non-invasive stimulation activates the vagus nerve," has been accepted for publication in Frontiers in Neuroscience.

globenewswire.com - 2026-06-09 08:00:00

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort & Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.

globenewswire.com - 2026-06-02 08:00:00

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

ROCKAWAY, N. J. , June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort and Casino in Las Vegas, NV.

globenewswire.com - 2026-06-02 08:00:00

electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference

electroCore NASDAQ: ECOR Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health care, commercial insurance channels and consumer wellness markets.

marketbeat.com - 2026-05-19 03:03:50

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network Open titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.

globenewswire.com - 2026-05-13 08:00:00

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro Invitational XVI Conference being held at the Luxe Sunset Boulevard hotel in Los Angeles, CA.   Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.

globenewswire.com - 2026-05-08 20:00:00

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-07 05:51:19

electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates

electroCore, Inc. (ECOR) came out with a quarterly loss of $0.59 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.47 per share a year ago.

zacks.com - 2026-05-06 19:36:00

electroCore Announces First Quarter 2026 Financial Results

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year period to $2.3 million Company to host a conference call and webcast today, May 6, 2026, at 4:30 pm EDT ROCKAWAY, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced financial results for the first quarter ended March 31, 2026.

globenewswire.com - 2026-05-06 16:05:00

Ecora Royalties has confirmed a strong start to 2026 - ICYMI

Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) this week outlined a strong start to 2026, with CEO Marc Bishop Lafleche highlighting significant growth in its base metals portfolio and a pipeline of catalysts to drive further upside. Speaking to Proactive, Lafleche said the company had delivered a “very strong quarter,” underpinned by a 152% increase in base metals royalties compared with the same period in 2025.

proactiveinvestors.co.uk - 2026-05-02 06:22:21

Ecora Royalties PLC to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 6th

LONDON, April 30, 2026 (GLOBE NEWSWIRE) -- Ecora Royalties PLC (LSE/TSX: ECOR, OTCQX: ECRAF), the London based critical minerals focused royalty and streaming company, announces that Geoff Callow, Head of Investor Relations, will present live at the Precious Metals & Critical Minerals Virtual Investor Conference hosted by VirtualInvestorConferences.com, on May 6th, 2026. DATE: May 6th     TIME: 10 – 10:30am ET REGISTER HERE Available for 1x1 meetings: May 6th.

globenewswire.com - 2026-04-30 08:31:00

electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026

ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the first quarter ended March 31, 2026, after the close of the market on Wednesday, May 6, 2026.

globenewswire.com - 2026-04-29 08:00:00

Ecora Royalties reveals "solid start" to year

Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR), in its first-quarter trading update, told investors that its portfolio contribution more than doubled, as its base metals assets carried the weight of the period, helped by higher cobalt and copper-linked income. The critical minerals royalty and streaming group reported a portfolio contribution of US$12.3 million for the three months, to 31 March, up 105% from US$6 million a year earlier.

proactiveinvestors.co.uk - 2026-04-29 02:53:56

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers Investor Summit at the historic Bank of New York. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.

globenewswire.com - 2026-04-28 08:00:00

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

ROCKAWAY, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced its participation in Hacking the Vagus Nerve, a documentary from the Healing Journeys series produced by The Root Cause Project and The Vagus Nerve Society. The film explores the role of the vagus nerve in regulating stress, mood, and immune function and features expert commentary from Peter S. Staats, MD, MBA, Chief Medical Officer of electroCore, and founder of the Vagus Nerve Society, alongside other leading physicians in the field.

globenewswire.com - 2026-04-23 08:00:00

Get ECOR Insider Trade Alerts

ECOR Price Target Summary

Last Month

$

0 analysts

Last Quarter

$

0 analysts

Last Year

$

0 analysts

All Time

$

0 analysts

ECOR Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-01-26 HC Wainwright & Co. Maintain Buy Buy
2025-03-13 Ladenburg Thalmann Maintain Buy Buy
2025-03-13 HC Wainwright & Co. Maintain Buy Buy
2024-12-18 HC Wainwright & Co. Maintain Buy Buy
2024-03-14 HC Wainwright & Co. Maintain Buy Buy
2024-01-22 HC Wainwright & Co. Maintain Buy Buy
2023-11-09 HC Wainwright & Co. Maintain Buy Buy
2023-08-10 HC Wainwright & Co. Maintain Buy Buy
2023-05-04 HC Wainwright & Co. Maintain Buy Buy
2023-04-18 HC Wainwright & Co. Maintain Buy Buy
2022-01-19 HC Wainwright & Co. Maintain Buy Buy
2020-08-14 BTIG Upgrade Neutral Buy
2020-08-14 HC Wainwright & Co. Maintain Buy Buy
2020-03-24 Cantor Fitzgerald Maintain Neutral Neutral
2019-11-14 Cantor Fitzgerald Maintain Neutral Neutral
2019-11-14 JMP Securities Downgrade Outperform Market Perform
2019-05-15 Cantor Fitzgerald Maintain Overweight Overweight
2019-05-15 BTIG Research Downgrade Buy Neutral